Trials / Completed
CompletedNCT01404481
Clean Intermittant Self Catheterisation: A Trial Comparing Single Use vs Reuse of Nelaton Catheters
Clean Intermittant Self Catheterisation: A Randomised Control Trial Comparing Single Use vs Reuse of Nelaton Catheters
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 23 (actual)
- Sponsor
- St George Hospital, Australia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to compare single use of catheters with reuse of catheters for intermittant self catheterisation.
Detailed description
Patients with voiding dysfunction and chronic urinary retention are taught the technique Clean Intermittent Self Catheterisation (CISC) by specialist Nurse Continence Advisors. For several decades, patients have been taught to catheterise using a "clean" technique where they rinse their catheter under tap water and store the catheter in a sterile solution (e.g. Milton). The catheter is re-used for up to one week. The risk of urinary tract infection (UTI) was known to be minimal (and certainly much less than having a permanent indwelling catheter). Recently, the Therapeutics Goods Administration has issued a guideline that CISC catheters should be "single-use items" but no data to support this guideline appears to have been collected. The aim of this project is to assess the incidence of urinary tract infection (UTI) when comparing single-use catheters with re-use of catheters for CISC, and to determine the cost differences between the two methods.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | clean intermittent self catheterisation single use vs re use | Over the 16 week period all patient will participate in 8 weeks of single use cathetersation and 8 weeks of re use catheterisation. The study is a randomised control crossover trial |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2011-07-28
- Last updated
- 2015-07-24
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT01404481. Inclusion in this directory is not an endorsement.